The groundbreaking treatment of this peptide represents a major advance in the management of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing improved glucose control and anticipated weight reduction. Experts are investigatin… Read More